This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Boehringer Ingelheim International Gmbh. Active years: 2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2021
Title: Elaine Ee-Ling Wang: Innovator in Anti-IL-23 Antibodies
Introduction
Elaine Ee-Ling Wang is a prominent inventor based in Toronto, Canada. She has made significant contributions to the field of biotechnology, particularly in the development of therapeutic antibodies. Her work focuses on innovative solutions that address critical health challenges.
Latest Patents
Elaine Wang holds a patent for anti-IL-23 antibodies. This invention relates to anti-IL-23p19 binding compounds, specifically new humanized anti-IL-23p19 antibodies. The patent also includes pharmaceutical compositions and therapeutic and diagnostic methods for utilizing these antibodies effectively.
Career Highlights
Elaine Wang is currently employed at Boehringer Ingelheim International GmbH, a leading global pharmaceutical company. Her role involves research and development in the area of therapeutic antibodies, where she applies her expertise to create impactful medical solutions.
Collaborations
Throughout her career, Elaine has collaborated with notable colleagues, including Patrick Garidel and Torsten Schultz-Fademrecht. These partnerships have enhanced her research and contributed to the advancement of innovative therapies.
Conclusion
Elaine Ee-Ling Wang is a trailblazer in the field of biotechnology, with her patent on anti-IL-23 antibodies showcasing her commitment to improving healthcare. Her work continues to inspire advancements in therapeutic solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile